| A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838) (NCT02532855) | Merck Sharp & Dohme LLC | 2015-10-20 |
| Memory Aid by Intranasal Insulin in Diabetes (MemAID) (NCT02415556) | Beth Israel Deaconess Medical Center | 2015-10-06 |
| A Post-Marketing Surveillance Study on NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Participants in Korea (NCT04980014) | Takeda | 2015-10-02 |
| Diabetes em Movimento® - Community-based Lifestyle Intervention Program for Patients With Type 2 Diabetes (NCT02631902) | University of Trás-os-Montes and Alto Douro | 2015-10-01 |
| Benfotiamine Effect on Advanced Glycation End Products(AGEs) and Soluble Receptor for AGEs(sRAGE) in Diabetes Mellitus. (NCT02772926) | Universidad de Guanajuato | 2015-10-01 |
| Study of HTD4010 in Healthy Volunteers (NCT02538848) | HighTide Therapeutics (Hong Kong) Limited | 2015-10-01 |
| Intergenerational mHealth Diabetes Program OPPORTUNITIES PROGRAM IN TAIWAN (NCT02971241) | University of Southern California | 2015-10-01 |
| Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM (NCT02597400) | Hua Medicine Limited | 2015-10-01 |
| Bexagliflozin Efficacy and Safety Trial (NCT02558296) | Theracos | 2015-10-01 |
| Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM (NCT02581657) | PhaseBio Pharmaceuticals Inc. | 2015-10-01 |
| A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin (NCT02554877) | Pfizer | 2015-10-01 |
| Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea (NCT02471404) | AstraZeneca | 2015-09-21 |
| Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL) (NCT02545842) | Sanofi | 2015-09-07 |
| Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes (NCT02745808) | Chinese Academy of Sciences | 2015-09-01 |
| Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM (NCT02526524) | Elcelyx Therapeutics, Inc. | 2015-09-01 |
| Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus (NCT02455011) | REMD Biotherapeutics, Inc. | 2015-09-01 |
| Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes (NCT02548741) | University of Arizona | 2015-09-01 |
| Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes (NCT02579148) | Leilei Zhu | 2015-09-01 |
| A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus (NCT02562326) | Adocia | 2015-09-01 |
| Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study) (NCT02512523) | Handok Inc. | 2015-08-27 |
| A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Disease (NCT02512068) | Takeda | 2015-08-07 |
| Tofogliflozin GLP-1 Analogue Combination Trial (NCT02537834) | Kowa Company, Ltd. | 2015-08-01 |
| Effect of Dapagliflozin on Glycemic Variability (NCT02459353) | The Catholic University of Korea | 2015-08-01 |
| Visualizing Beta Cells After Bariatric Surgery (NCT02542059) | Radboud University Medical Center | 2015-08-01 |
| Sitagliptin Therapy and Kinetics of Inflammatory Markers (NCT02536248) | Laval University | 2015-08-01 |
| ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD (NCT02330549) | Tobira Therapeutics, Inc. | 2015-07-17 |
| Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia (NCT02517866) | Takeda | 2015-07-13 |
| A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes (NCT02514850) | Adocia | 2015-07-01 |
| Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes (NCT02537470) | BHV Pharma | 2015-07-01 |
| Novel Model for South Asian Treatment in Diabetes (NaMaSTe-Diabetes) Trial in Primary Care (NCT02136654) | University of British Columbia | 2015-07-01 |
| Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes (NCT02370719) | University Health Network, Toronto | 2015-06-28 |
| A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (NCT02452632) | Astellas Pharma Korea, Inc. | 2015-06-22 |
| A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes (NCT02413398) | AstraZeneca | 2015-06-15 |
| Effects of Ginger Supplementation on NF-KB in Peripheral Blood Mononuclear Cells in Type 2 Diabetes Mellitus (NCT02666807) | Tehran University of Medical Sciences | 2015-06-01 |
| Physical Activity and Participation (NCT02268916) | VA Office of Research and Development | 2015-06-01 |
| Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in Humans (NCT02459106) | AdventHealth Translational Research Institute | 2015-05-27 |
| Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology (NCT02401880) | Profil Institut für Stoffwechselforschung GmbH | 2015-05-01 |
| Non-inteRvEntional Study to Observe rAtionaLe to Select add-on TherapY for Type 2 Diabetes Inadequately Controlled With Metformin. (NCT02355145) | AstraZeneca | 2015-04-02 |
| TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus (NCT02430870) | Takeda | 2015-04-01 |
| Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus (NCT02434744) | Response Pharmaceuticals | 2015-04-01 |
| A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers (NCT02375139) | Dong-A ST Co., Ltd. | 2015-04-01 |
| Effects of Physical Exercise on Blood Glucose and Pain From the Musculoskeletal System in Patients With Type 2 Diabetes (NCT02366416) | Nordsjaellands Hospital | 2015-04-01 |
| Comparative Interventional Study to Evaluate the Role of LRYGBP, LSG & SMM (NCT04058730) | Max Institute of Minimally Access, Metabolic & Bariatric Surgery | 2015-04-01 |
| Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects (NCT02447601) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2015-03-30 |
| Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus (NCT05697991) | King Saud University | 2015-03-23 |
| Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus (NCT02426541) | AstraZeneca | 2015-03-23 |
| Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients (NCT02411825) | Sanofi | 2015-03-01 |
| Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients (NCT02401243) | Sanofi | 2015-03-01 |
| Form of Dairy Products on Satiety, Food Intake and Post-meal Glycaemia in Young and Older Adults (NCT02491801) | University of Toronto | 2015-03-01 |
| Trial to Incentivise Adherence for Diabetes (NCT02224417) | Duke-NUS Graduate Medical School | 2015-03-01 |
| A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT02367066) | AstraZeneca | 2015-03-01 |
| Alkaline Diet for Insulin Sensitivity (NCT02501343) | Garvan Institute of Medical Research | 2015-03-01 |
| The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients (NCT02366351) | Jiangsu HengRui Medicine Co., Ltd. | 2015-02-01 |
| Safety, Tolerability and PK of Imeglimin in Japanese Volunteers (NCT02373150) | Poxel SA | 2015-02-01 |
| Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function (NCT02467790) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2015-02-01 |
| The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients (NCT02366377) | Jiangsu HengRui Medicine Co., Ltd. | 2015-02-01 |
| Mind-motor Exercise in Older Adults With Type 2 Diabetes and Self-reported Cognitive Complaints (NCT02292511) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2015-02-01 |
| A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus (NCT02419859) | CeQur Corporation | 2015-02-01 |
| Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin (NCT02426294) | Pusan National University Hospital | 2015-02-01 |
| Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes (NCT02380521) | University of Palermo | 2015-01-01 |
| Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine (NCT02294474) | Sanofi | 2015-01-01 |
| Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin) (NCT02354235) | Tanabe Pharma Corporation | 2015-01-01 |
| Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients (NCT02344641) | Chinese Academy of Medical Sciences, Fuwai Hospital | 2015-01-01 |
| Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional (NCT02336945) | Abbott Diabetes Care | 2015-01-01 |
| Effect of Nutritional Counseling Based on Diet Quality on Metabolic Control in Patients With Type 2 Diabetes Mellitus (NCT02488213) | Hospital de Clinicas de Porto Alegre | 2015-01-01 |
| Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications (NCT02320721) | Sanofi | 2015-01-01 |
| Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin) (NCT02354222) | Tanabe Pharma Corporation | 2015-01-01 |
| A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy (NCT02292433) | Pfizer | 2015-01-01 |
| DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings (NCT02322762) | AstraZeneca | 2014-12-30 |
| A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes (NCT02324569) | Takeda | 2014-12-27 |
| Raspberries and Postprandial Metabolism (NCT03403582) | Oklahoma State University | 2014-12-01 |
| IL-1RA, Acute Exercise, and Beta-cell Function (NCT02310009) | Rigshospitalet, Denmark | 2014-12-01 |
| Diabetes Prevention Among Post-partum Women With History of Gestational Diabetes (NCT02240420) | University of California, San Francisco | 2014-12-01 |
| Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control (NCT02273050) | AstraZeneca | 2014-12-01 |
| Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus (NCT02622113) | Tanabe Pharma Corporation | 2014-12-01 |
| Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis (NCT02169570) | Dow University of Health Sciences | 2014-12-01 |
| Effectiveness of Automated Mobile Phone Based Text Messaging on the Improvement of Glycaemic Outcomes (NCT02643277) | India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals | 2014-12-01 |
| Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin (NCT02343926) | Sanofi | 2014-12-01 |
| Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin (NCT02168491) | Medical University of Vienna | 2014-11-01 |
| Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients (NCT02324842) | The University of Texas Health Science Center at San Antonio | 2014-11-01 |
| MedStar Health Type 2 Diabetes Pathway to Control (NCT02925312) | Medstar Health Research Institute | 2014-11-01 |
| REAL HEALTH-Diabetes: Reach Ahead for Lifestyle and Health-Diabetes (NCT02320253) | Massachusetts General Hospital | 2014-11-01 |
| The Role of Arachidonic Acid Metabolites, From Patients With Metabolic Syndrome (NCT02498119) | University of Malaya | 2014-11-01 |
| Glycemic and Satiety Response Study of Fibre-Enriched Pudding Products (NCT02289612) | University of Guelph | 2014-11-01 |
| A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020) (NCT02411929) | Merck Sharp & Dohme LLC | 2014-10-29 |
| Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM) (NCT02291874) | Astellas Pharma Inc | 2014-10-08 |
| Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use (NCT02200666) | AstraZeneca | 2014-10-03 |
| Determinants of Diabetes Remission After Gastric Bypass Surgery (NCT02287285) | Blandine Laferrere | 2014-10-01 |
| GOS and Insulin Sensitivity (NCT02271776) | Maastricht University Medical Center | 2014-10-01 |
| Using Combined Instantaneous and Multidimensional Feedback to Support a Change in Physical Activity Behaviour (NCT02432924) | University of Bath | 2014-10-01 |
| Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit (NCT02250794) | Rush University Medical Center | 2014-10-01 |
| Bariatric Surgery for the Treatment of Type 2 Diabetes - Clinical Effects and Underlying Mechanisms (NCT02729246) | Uppsala University | 2014-10-01 |
| An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients (NCT02435277) | NuSirt Biopharma | 2014-10-01 |
| Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus (NCT02250222) | Ligand Pharmaceuticals | 2014-10-01 |
| Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance (NCT02252224) | AstraZeneca | 2014-09-23 |
| Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017) (NCT02226003) | Merck Sharp & Dohme LLC | 2014-09-23 |
| DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan (NCT02226822) | AstraZeneca | 2014-09-20 |
| Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014) (NCT02115347) | Merck Sharp & Dohme LLC | 2014-09-19 |
| A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus (NCT02211261) | Pfizer | 2014-09-15 |
| The Practical Evidence of Antidiabetic Combination Therapy in Korea (NCT02231021) | Kun-Ho Yoon | 2014-09-01 |